ATH 0.00% 0.4¢ alterity therapeutics limited

Ann: New commercial opportunity for PBT2, page-26

  1. 1,640 Posts.
    lightbulb Created with Sketch. 143
    PBT2 seems to have loads of game changing potential. lets just hope we are all around to reap the benefits ( both financial and in health ) before we pass on.

    The big question is ... are the doses required to be clinically significant to be used as antimicrobial treatment already within the parameters the FDA set as requirement for safety for dogs in further trials.. if it is then game on .. ( and hopefully sooner rather than later )

    full disclosure i put a little back in at this level, but still have some cash in the wings. this is a very strong reason for a good surge though.
    Last edited by m123456: 22/12/20
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $0 51

Buyers (Bids)

No. Vol. Price($)
102 103948983 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 31829254 17
View Market Depth
Last trade - 09.59am 29/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.